Cargando…

In silico analysis of protein/peptide-based inhalers against SARS-CoV-2

Aim: Peptide/protein-based inhalers are excessively used to treat respiratory disorders. The molecular docking was performed for these inhalers including human neutralizing S230 light chain-antibody (monoclonal antibodies [mAbs]), alpha-1-antitrypsin (AAT), short-palate-lung and nasal-epithelial clo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salman, Saad, Shah, Fahad Hassan, Chaudhry, Maham, Tariq, Muniba, Akbar, Muhammad Yasir, Adnan, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543042/ http://dx.doi.org/10.2217/fvl-2020-0119

Ejemplares similares

In silico study of thymohydroquinone interaction with blood–brain barrier disrupting proteins
por: Shah, Fahad Hassan, et al.
Publicado: (2020)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2—An in silico glance
por: Marchan, Jose
Publicado: (2020)

In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations
por: Khan, Abbas, et al.
Publicado: (2021)

Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
por: Mahmud, Shafi, et al.
Publicado: (2021)

SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study
por: Khan, Muhammad Tahir, et al.
Publicado: (2020)

In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)

Detection of SARS-CoV-2 in ophthalmic secretions
por: Arshad, Yasir, et al.
Publicado: (2021)

Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key
por: Al Awaidy, Salah T., et al.
Publicado: (2021)

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis
por: Marciniec, Krzysztof, et al.
Publicado: (2020)

In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome
por: Alhatlani, Bader Y
Publicado: (2020)

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
por: Tomita, Yusuke, et al.
Publicado: (2020)

Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity
por: Hanifa, Muhammad, et al.
Publicado: (2023)

Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis
por: Dar, Hamza Arshad, et al.
Publicado: (2020)

Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis
por: Vavougios, George D.
Publicado: (2020)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

SARS-COV-2 Presenting as New Onset Atrial Fibrillation: A Case Report
por: Harhay, Jason, et al.
Publicado: (2020)

Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
por: Rehman, Muhammad Fayyaz ur, et al.
Publicado: (2021)

Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
por: Ismail, Muhammad I., et al.
Publicado: (2021)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020)

In silico exploration of enzymes involved in sialic acid biosynthesis and their possible role in SARS-CoV-2 infection
por: Divya, V.C., et al.
Publicado: (2021)

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease
por: Imran, Muhammad, et al.
Publicado: (2022)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
por: Biembengut, Ísis Venturi, et al.
Publicado: (2020)

In silico analysis of mismatches in RT-qPCR assays of 177 SARS-CoV-2 sequences from Brazil
por: Santos, Renan da Silva, et al.
Publicado: (2020)

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery
por: Khattab, Amira R, et al.
Publicado: (2022)

In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
por: Alanzi, Abdullah R, et al.
Publicado: (2023)

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2
por: Liscano, Yamil, et al.
Publicado: (2020)

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
por: Chidambaram, Sathish Kumar, et al.
Publicado: (2020)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
por: Khan, Taimoor, et al.
Publicado: (2022)

In silico designing of multiepitope-based-peptide (MBP) vaccine against MAPK protein express for Alzheimer's disease in Zebrafish
por: Arfat, Yasir, et al.
Publicado: (2023)

Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors
por: Salman, Saad, et al.
Publicado: (2020)

Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico
por: Quayum, Syeda Tasnim, et al.
Publicado: (2021)

Peptide inhibitors against SARS-CoV-2 2′-O-methyltransferase involved in RNA capping: A computational approach
por: Dutta, Mainak, et al.
Publicado: (2021)

Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection
por: Tariq, Mehlayl, et al.
Publicado: (2022)

In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
por: Singh, Pushpendra, et al.
Publicado: (2021)

Silibinin as potential tool against SARS‐Cov‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects
por: Speciale, Antonio, et al.
Publicado: (2021)

Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies
por: Muhammad, Shabbir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tr8emjeptjjavqe1766mohgm0m